Novo Nordisk CEO Steps Down

Sep 01, 2016

Reuters

Novo Nordisk's veteran CEO Lars Rebien Sorensen has announced that he will step down earlier than planned.

Sorensen had said in April 2015 that he would remain in his role until he approached the end of his contract, expiring in 2019. The early retirement announcement comes as Novo says it has shaken up its management team to cope with “extraordinary change” and sharp headwinds for its core diabetes business.

Sorensen will be succeeded from January by Lars Fruergaard Jorgensen, currently executive vice president and head of corporate development.

Read the Reuters coverage

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments